mutational status of the brca genes Search Results


her2 breast cancer • identified pik3ca status  (Novartis)
86
Novartis her2 breast cancer • identified pik3ca status
Her2 Breast Cancer • Identified Pik3ca Status, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mutational+status+of+the+brca+genes/mutation+pik3ca/fda_document____cdrh_docs_slash_pdf19_slash_p190004b-355-61-74
Average 86 stars, based on 1 article reviews
her2 breast cancer • identified pik3ca status - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
brca2 mutation carriers  (STATA Corporation)
99
STATA Corporation brca2 mutation carriers
Previously Published Breast and Ovarian Cancer Risks Associated with Mutations in BRCA1 and <t> BRCA2 </t>
Brca2 Mutation Carriers, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mutational+status+of+the+brca+genes/STATA+7%2E0/pmc01180265-167-19-32
Average 99 stars, based on 1 article reviews
brca2 mutation carriers - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
brca1 2 mutation status  (Foundation Medicine Inc)
99
Foundation Medicine Inc brca1 2 mutation status
Previously Published Breast and Ovarian Cancer Risks Associated with Mutations in BRCA1 and <t> BRCA2 </t>
Brca1 2 Mutation Status, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mutational+status+of+the+brca+genes/FoundationOne+CDx/pm40007558-54-7-13
Average 99 stars, based on 1 article reviews
brca1 2 mutation status - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
chi-square test  (CH Instruments)
90
CH Instruments chi-square test
Previously Published Breast and Ovarian Cancer Risks Associated with Mutations in BRCA1 and <t> BRCA2 </t>
Chi Square Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mutational+status+of+the+brca+genes/chi+square+test/pmc08025729-47-3-16
Average 90 stars, based on 1 article reviews
chi-square test - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
brca mutation status  (23andMe)
90
23andMe brca mutation status
<t> BRCA </t> Test Results.
Brca Mutation Status, supplied by 23andMe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mutational+status+of+the+brca+genes/brca+mutation+status/pmc03628894-147-7-17
Average 90 stars, based on 1 article reviews
brca mutation status - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
brca1 mutations  (STATA Corporation)
99
STATA Corporation brca1 mutations
Demographics of pancreatic cancer patients who underwent <t> BRCA1 </t> gene sequence analysis
Brca1 Mutations, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mutational+status+of+the+brca+genes/STATA+9%2E0/pmc02684337-131-8-23
Average 99 stars, based on 1 article reviews
brca1 mutations - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
genetic test for brca1 and brca2  (FALCO Biosystems Ltd)
90
FALCO Biosystems Ltd genetic test for brca1 and brca2
Demographics of pancreatic cancer patients who underwent <t> BRCA1 </t> gene sequence analysis
Genetic Test For Brca1 And Brca2, supplied by FALCO Biosystems Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mutational+status+of+the+brca+genes/brca1+and+brca2+testing/pm28179634-52-5-24
Average 90 stars, based on 1 article reviews
genetic test for brca1 and brca2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Previously Published Breast and Ovarian Cancer Risks Associated with Mutations in BRCA1 and BRCA2

Journal:

Article Title: Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

doi:

Figure Lengend Snippet: Previously Published Breast and Ovarian Cancer Risks Associated with Mutations in BRCA1 and BRCA2

Article Snippet: Statistical Methods Kaplan-Meier estimation.— The cumulative probabilities of breast and ovarian cancer in mothers and sisters of BRCA1- and BRCA2- mutation carriers were estimated using the Kaplan-Meier product-limit method, using the program Stata (version 7).

Techniques:

Description of Studies Included in the Present Analysis

Journal:

Article Title: Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

doi:

Figure Lengend Snippet: Description of Studies Included in the Present Analysis

Article Snippet: Statistical Methods Kaplan-Meier estimation.— The cumulative probabilities of breast and ovarian cancer in mothers and sisters of BRCA1- and BRCA2- mutation carriers were estimated using the Kaplan-Meier product-limit method, using the program Stata (version 7).

Techniques: Sequencing

Kaplan-Meier cumulative breast (upper lines) and ovarian (lower lines) cancer probability in sisters (thick lines) and mothers (thin lines) of BRCA2-mutation–carrying index case patients.

Journal:

Article Title: Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

doi:

Figure Lengend Snippet: Kaplan-Meier cumulative breast (upper lines) and ovarian (lower lines) cancer probability in sisters (thick lines) and mothers (thin lines) of BRCA2-mutation–carrying index case patients.

Article Snippet: Statistical Methods Kaplan-Meier estimation.— The cumulative probabilities of breast and ovarian cancer in mothers and sisters of BRCA1- and BRCA2- mutation carriers were estimated using the Kaplan-Meier product-limit method, using the program Stata (version 7).

Techniques: Mutagenesis

Cumulative risk of breast (♦) and ovarian (▪) cancer in BRCA2-mutation carriers.

Journal:

Article Title: Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

doi:

Figure Lengend Snippet: Cumulative risk of breast (♦) and ovarian (▪) cancer in BRCA2-mutation carriers.

Article Snippet: Statistical Methods Kaplan-Meier estimation.— The cumulative probabilities of breast and ovarian cancer in mothers and sisters of BRCA1- and BRCA2- mutation carriers were estimated using the Kaplan-Meier product-limit method, using the program Stata (version 7).

Techniques: Mutagenesis

RRs for Mutation Carriers, as Compared to Baseline, for Models Allowing for Center, Type-of-Index-Case, and Year-of-Birth Effects [Note]

Journal:

Article Title: Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

doi:

Figure Lengend Snippet: RRs for Mutation Carriers, as Compared to Baseline, for Models Allowing for Center, Type-of-Index-Case, and Year-of-Birth Effects [Note]

Article Snippet: Statistical Methods Kaplan-Meier estimation.— The cumulative probabilities of breast and ovarian cancer in mothers and sisters of BRCA1- and BRCA2- mutation carriers were estimated using the Kaplan-Meier product-limit method, using the program Stata (version 7).

Techniques: Mutagenesis

BRCA Test Results.

Journal: PeerJ

Article Title: Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing

doi: 10.7717/peerj.8

Figure Lengend Snippet: BRCA Test Results.

Article Snippet: At the conclusion of the interviews, the BRCA mutation status of each participant was verified from the 23andMe database.

Techniques: Mutagenesis

Sharing of BRCA Results.

Journal: PeerJ

Article Title: Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing

doi: 10.7717/peerj.8

Figure Lengend Snippet: Sharing of BRCA Results.

Article Snippet: At the conclusion of the interviews, the BRCA mutation status of each participant was verified from the 23andMe database.

Techniques:

Taking Action After Positive 23andMe BRCA Result.

Journal: PeerJ

Article Title: Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing

doi: 10.7717/peerj.8

Figure Lengend Snippet: Taking Action After Positive 23andMe BRCA Result.

Article Snippet: At the conclusion of the interviews, the BRCA mutation status of each participant was verified from the 23andMe database.

Techniques: Imaging

Demographics of pancreatic cancer patients who underwent BRCA1 gene sequence analysis

Journal:

Article Title: Absence of germline BRCA1 mutations in Familial Pancreatic Cancer Patients

doi:

Figure Lengend Snippet: Demographics of pancreatic cancer patients who underwent BRCA1 gene sequence analysis

Article Snippet: Data Analysis Prevalence and 95% confidence intervals of BRCA1 mutations, as well as analysis of pathological and family history data, was performed using STATA v9.0.

Techniques: Sequencing, Biomarker Discovery